Cis double PIK3CA mutations are common in cancers and increase sensitivity to PI3Kα inhibitors. Click to show full abstract
Cis double PIK3CA mutations are common in cancers and increase sensitivity to PI3Kα inhibitors.
               
Click one of the above tabs to view related content.